SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData
Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » dapagliflozin
Browsing Tag
dapagliflozin
Diabetes drug, Dapagliflozin shows benefits in patients with CKD
The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV)…
Glenmark gets tentative USFDA approval for generic anti-diabetes tablets
The approval is for the strength of 10 mg/5 mg tablets
Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India
Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India…
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'
